Varian Image-Guided Radiation Therapy Shipments To Begin Mid-Year
This article was originally published in The Gray Sheet
Executive Summary
Varian Medical Systems expects FDA clearance of its On-Board Imaging tumor tracking accessory by spring to fill out its initial image-guided radiation therapy (IGRT) lineup
You may also be interested in...
Varian, Boston Scientific FDA Approvals Aid Q1 Double-Digit Stock Gains
Varian Medical Systems' receipt of 510(k) clearance for its On-Board Imaging tumor tracking accessory helped the radiation oncology firm's stock soar 24.9% in the first quarter - jumping $17.21 to close at $86.31
Incyte Hopes To Augment Immune/Inflammation Pipeline With Escient Deal
Incyte will pay $750m to acquire privately held Escient and its first-in-class oral antagonists of Mas-related G protein-coupled receptors X2 and X4.